Gilbert, M., Yuan, Y., Wani, K., Wu, J., Omuro, A., Lieberman, F., . . . Aldape, K. (2014). AT-23 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL. Oxford University Press.
Chicago Style CitationGilbert, Mark, et al. AT-23 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL. Oxford University Press, 2014.
Cita MLAGilbert, Mark, et al. AT-23 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL. Oxford University Press, 2014.
Atenció: Aquestes cites poden no estar 100% correctes.